Indaptus Therapeutics
INDP
14 hedge funds and large institutions have $1.11M invested in Indaptus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
3% more capital invested
Capital invested by funds: $1.08M → $1.11M (+$30.2K)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more ownership
Funds ownership: 0.25% → 0.25% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHL
Investment House LLC
Redondo Beach,
California
|
+$26.4K |
| 2 |
Renaissance Technologies
New York
|
+$3.33K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Strategy Asset Managers
Pasadena,
California
|
-$20.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$992 |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$35 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $478K | – | – | – |
|
|
IHL
2
Investment House LLC
Redondo Beach,
California
| $207K | +$26.4K | +452 | +13% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $92.5K | – | – | – |
|
|
SAM
4
Strategy Asset Managers
Pasadena,
California
| $86.6K | -$20.8K | -357 | -18% |
|
|
PVI
5
Pine Valley Investments
Marlton,
New Jersey
| $84.8K | – | – | – |
|
|
VCM
6
Vivaldi Capital Management
Chicago,
Illinois
| $45.8K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $40K | +$3.33K | +57 | +8% |
|
8
State Street
Boston,
Massachusetts
| $35.6K | – | – | – |
|
9
Northern Trust
Chicago,
Illinois
| $24.7K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $10.8K | -$992 | -17 | -8% |
|
11
Morgan Stanley
New York
| $1.58K | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $1.22K | +$1.34K | +23 | New |
|
|
BSB
13
Bangor Savings Bank
Bangor,
Maine
| $764 | – | – | – |
|
14
Wells Fargo
San Francisco,
California
| $193 | – | – | – |
|
15
Group One Trading
Chicago,
Illinois
| $13 | – | – | – |
|
|
16
Osaic Holdings
Scottsdale,
Arizona
| – | -$35 | -1 | Closed |
|
INDP Hedge Fund Activity: Q2 2023 in Review
14 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q2 2023, worth a combined $1.11M — up 2.8% from $1.08M a quarter earlier.
Fund positioning in INDP was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Investment House LLC, adding an estimated $26.4K. The largest seller was Strategy Asset Managers, cutting an estimated $20.8K.
- 14 institutional investors held Indaptus Therapeutics (INDP) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $1.11M of Indaptus Therapeutics stock for Q2 2023, up 2.8% quarter-over-quarter.
- 1 fund opened new Indaptus Therapeutics positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest Indaptus Therapeutics buyer in Q2 2023 was Investment House LLC, an estimated $26.4K added.
- The largest Indaptus Therapeutics seller in Q2 2023 was Strategy Asset Managers, an estimated $20.8K sold.
Based on aggregated 13F filings for Q2 2023.